Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
addressing, announced, biomarker, biopharmaceutical, comprised, extinguishment, gain, hospital, inability, prioritization, reallocate, representation, screening, upcoming
Removed:
absenteeism, accounted, accrue, amortized, appeal, apply, applying, bankruptcy, BCF, begin, beneficial, bid, binomial, calendar, call, Canada, chain, characterized, classify, collaborator, collect, commence, commencing, Conformit, consecutive, consent, consolidation, convert, creditor, cure, customary, declared, deducting, default, Deferment, delist, delisting, deliver, Department, depression, derivative, disbursement, Distinguishing, dollar, doubt, earlier, effecting, event, expire, exploring, factoring, failure, feature, forced, forfeited, forward, freestanding, fully, inclusive, incurring, indexed, inform, inoperable, instrument, intention, interruption, inversely, involving, issuer, judgment, launch, letter, limit, listed, locally, location, long, making, mandatorily, mandatory, manufacture, Marketplace, merger, met, modifying, monetary, negotiated, noncash, notification, notify, notifying, Ontario, open, organized, owing, ownership, paragraph, pause, paying, payroll, placement, preceding, preclinical, predominantly, prepay, prepayment, previously, primary, productization, prolonged, promissory, proportionate, prototype, put, qualify, recession, recommended, redeemable, regain, registering, relating, render, reorganization, repay, repayment, represented, repurchase, request, requirement, resale, resolve, reverse, reviewed, satisfied, satisfying, secondary, Secretary, secured, separate, settleable, settled, significantly, simple, split, strain, structure, study, submission, suit, supplier, supply, surfaced, targeting, temporary, thereof, traded, trading, transferring, translate, unamortized, unexercised, unforeseen, utilizing, validate, variable, VWAP, Wainwright, wholly, worsen, Wuhan
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Associated NDRA transcripts
NDRA similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of ENDRA Life Sciences Inc. (the “Company”) on Form 10-Q for the period March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Francois Michelon, Chief Executive Officer and Chairman of the Company, and David Wells, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906 has been provided to ENDRA Life Sciences Inc. and will be retained by ENDRA Life Sciences Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
/s/ Francois Michelon | /s/ David Wells | |||
Francois Michelon | David Wells | |||
Chief Executive Officer and Chairman | Chief Financial Officer |